Saharnaz Nedjat

The promise of deep urine proteomics for diagnosis of cancer, neurologic, and metabolic diseases

Introduction Urine offers a noninvasive and low-cost source of disease biomarkers, yet most proteomic studies have targeted single conditions. Using deep proteomic profiling and machine learning, we evaluated whether urinary protein signatures distinguish early-stage cancer, neurologic, and metabolic diseases from heal...